Journal of Infection and Chemotherapy

Papers
(The H4-Index of Journal of Infection and Chemotherapy is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient76
Comparative evaluation of nasopharyngeal swab and saliva specimens for the molecular detection of SARS-CoV-2 RNA in Japanese patients with COVID-1968
Surveillance in hospitalized children with infectious diseases in Japan: Pre- and post-coronavirus disease 201944
Suspected cholestatic liver injury induced by favipiravir in a patient with COVID-1943
Ventilator-associated bacterial pneumonia in coronavirus 2019 disease, a retrospective monocentric cohort study40
The evaluation of a newly developed antigen test (QuickNavi™-COVID19 Ag) for SARS-CoV-2: A prospective observational study in Japan40
Clinical characteristics of COVID-19 in hospitalized children during the Omicron variant predominant period39
Post COVID-19 condition of the Omicron variant of SARS-CoV-238
Clinical validation of quantitative SARS-CoV-2 antigen assays to estimate SARS-CoV-2 viral loads in nasopharyngeal swabs38
Adverse reactions to the BNT162b2 and mRNA-1273 mRNA COVID-19 vaccines in Japan37
Analysis of a persistent viral shedding patient infected with SARS-CoV-2 by RT-qPCR, FilmArray Respiratory Panel v2.1, and antigen detection35
Reactogenicity following two doses of the BNT162b2 mRNA COVID-19 vaccine: Real-world evidence from healthcare workers in Japan33
COVID-19 vaccine induced interstitial lung disease33
SARS-CoV-2 detection by fluorescence loop-mediated isothermal amplification with and without RNA extraction32
Comparison of COVID-19 disease between young and elderly patients: Hidden viral shedding of COVID-1930
Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial29
A meta-analysis of the target trough concentration of gentamicin and amikacin for reducing the risk of nephrotoxicity29
Immunochromatography and chemiluminescent enzyme immunoassay for COVID-19 diagnosis28
Evaluating a novel, highly sensitive, and quantitative reagent for detecting SARS-CoV-2 antigen27
Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-227
Efficacy and validity of automated quantitative chemiluminescent enzyme immunoassay for SARS-CoV-2 antigen test from saliva specimen in the diagnosis of COVID-1926
Asian guidelines for condyloma acuminatum26
Estimated effectiveness of school closure and voluntary event cancellation as COVID-19 countermeasures in Japan25
Asian guidelines for urinary tract infection in children25
Comparison of the clinical characteristics and outcomes of COVID-19 in children before and after the emergence of Delta variant of concern in Japan25
0.042101144790649